QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.057307v1 308/1/73    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chadman, K. K. Articles by Woods, J. H. Search for Related Content PubMed PubMed Citation Articles by Chadman, K. K. Articles by Woods, J. H.

CARDIOVASCULAR

Cardiovascular Effects of Nicotine, Chlorisondamine, and Mecamylamine in the Pigeon

Departments of Pharmacology (K.K.C., J.H.W.) and Psychology (J.H.W.), University of Michigan, Ann Arbor, Michigan

Chlorisondamine and mecamylamine are nicotinic antagonists that produce both ganglionic and central blockade. Chlorisondamine, when administered as a large systemic dose, produces a persistent central block, despite being charged. The present study evaluated the cardiovascular effects of chlorisondamine. Shortly after administration, chlorisondamine (0.10, 1, and 10 mg/kg i.m.) lowered blood pressure significantly and decreased heart rate at the low dose (0.1 mg/kg i.m.) and increased heart rate at the high dose (10 mg/kg i.m.). Mecamylamine (1 and 10 mg/kg i.m.) also lowered blood pressure and heart rate. After both antagonists, heart rate returned to baseline values within 90 min and blood pressure within 24 h. Low doses of nicotine (0.01-0.03 mg/kg i.m.) lowered blood pressure but did not affect heart rate. Higher doses (0.10-3.2 mg/kg i.m.) transiently increased blood pressure and heart rate. Subsequent to antagonist administration, nicotine was administered to determine whether either drug blocked the cardiovascular effects of nicotine. Chlorisondamine (0.1, 1, and 10 mg/kg i.m.) administered 30 min before nicotine blocked the increases in blood pressure and heart rate. Only the high dose (10 mg/kg i.m.) of chlorisondamine administered 24 h before nicotine produced a blockade of nicotine's pressor effect. This block diminished within 3 days. Mecamylamine (1 mg/kg i.m.) antagonized only nicotine's tachycardic effect. Longer pretreatment with mecamylamine (10 mg/kg, 24 h before nicotine challenge) did not antagonize the cardiovascular effects of nicotine. Thus, chlorisondamine produces a longer lasting blockade of nicotine's cardiovascular effects than mecamylamine.

Address correspondence to: James H. Woods, 1301 MSRB III, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-0632. E-mail: jhwoods{at}umich.edu

This article has been cited by other articles:

				M. D. Luyer, J. W. M. Greve, M. Hadfoune, J. A. Jacobs, C. H. Dejong, and W. A. Buurman Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve J. Exp. Med., October 17, 2005; 202(8): 1023 - 1029. [Abstract] [Full Text] [PDF]

				J. J. Buccafusco, J. A. Davis, L. C. Shuster, C. J. Buccafusco, and M. Gattu The Importance of Brainstem Cholinergic Neurons in the Pressor Response to Cocaine J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 179 - 191. [Abstract] [Full Text] [PDF]